Reference:
1. Merck & Co., Inc. Propecia® (Finasteride)Tablets,1 mg. Available form : www.accessdata.fda.gov/drugsatfda_docs/label/2011/020788Orig1s022lbl.pdf - 110k - 2011-06-17.
2. Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls PI, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges 2011;9 (suppl 6):S1–57.
3. Olsen EA, Messenger AG, Shapiro J, Bergfeld WF, Hordinsky MK, Roberts JL, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol 2005;52:301-11.
4. The Finasteride Male Pattern Hair Loss Study Group. Long term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol 2002;12:38-49.
Keywords:
-